Delivery of Antisense Oligonucleotides and Plasmid DNA with Various Carrier Agents
- 1 December 1999
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antisense and Nucleic Acid Drug Development
- Vol. 9 (6) , 497-505
- https://doi.org/10.1089/oli.1.1999.9.497
Abstract
A series of cationic nucleic acid carriers was evaluated for their ability to deliver pLuc plasmid DNA or a 2′-O-methyl-oligoribonucleoside phosphorothioate, ON-705. Oligonucleotide delivery and its antisense function were assayed by a recently developed assay based on alternative splicing of modified luciferase pre-mRNA (Kang et al., 1998). This assay scores only the nuclear and sequence-specific antisense activity of the oligonucleotides. The results show that the efficiencies of delivery of plasmid DNA and oligonucleotides by the tested carriers, with the exception of Exgene and Lipofectamine, differed markedly. The efficiency of the delivery of ON-705 oligonucleotide was reduced by 70%–90% for all carriers, except Effectene, in culture media containing 8% fetal bovine serum. Interestingly, the efficiency of delivery of the ON-705-Effectene complex increased with serum concentrations of up to 30%.Keywords
This publication has 33 references indexed in Scilit:
- Optimal Lipofection Reagent Varies with the Molecular Modifications of the DNAAntisense and Nucleic Acid Drug Development, 1998
- An Overview of Progress in Antisense TherapeuticsAntisense and Nucleic Acid Drug Development, 1998
- Effects of Complement Depletion on the Pharmacokinetics and Gene Delivery Mediated by Cationic Lipid–DNA ComplexesHuman Gene Therapy, 1998
- Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- Improved DNA: liposome complexes for increased systemic delivery and gene expressionNature Biotechnology, 1997
- Altered mRNA Splicing and Inhibition of Human E-selectin Expression by an Antisense Oligonucleotide in Human Umbilical Vein Endothelial CellsPublished by Elsevier ,1996
- Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.Journal of Clinical Investigation, 1996
- Fate of cationic liposomes and their complex with oligonucleotive in vivoBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996
- Antisense Gene Inhibition by Oligonucleotides Containing C-5 Propyne PyrimidinesScience, 1993
- Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cellsBiochemistry, 1993